Related Experiment Video

Updated: Jul 17, 2026

Generalized Psychophysiological Interaction (PPI) Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
09:38

Generalized Psychophysiological Interaction (PPI) Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Published on: November 14, 2017

Interaction between poly(ADP-ribose) polymerase 1 and interleukin 1A genes is associated with Alzheimer's disease

Jon Infante1, Javier Llorca, Ignacio Mateo

  • 1Neurology Service, Marqués de Valdecilla University Hospital, University of Cantabria, Santander, Spain.

Dementia and Geriatric Cognitive Disorders
|February 10, 2007
PubMed

Insights

Genetic variations in Poly(ADP-ribose) polymerase 1 (PARP-1) and Interleukin-1A (IL-1A) are linked to increased Alzheimer's disease (AD) risk. These PARP-1 gene polymorphisms, especially with IL-1A, may contribute to AD development.

Area of Science:

  • Neuroscience
  • Genetics
  • Immunology

Background:

  • Activated microglia release proinflammatory cytokines, contributing to neurodegeneration in Alzheimer's disease (AD).
  • Poly(ADP-ribose) polymerase 1 (PARP-1) influences inflammatory gene expression, including interleukin-1 (IL-1).
  • PARP-1 overactivity is observed in the AD brain, suggesting a potential role in disease pathogenesis.

Purpose of the Study:

  • To investigate if PARP-1 gene polymorphisms (-410 and -1672) increase susceptibility to AD.
  • To determine if these PARP-1 polymorphisms interact with the IL-1A -889 polymorphism to affect AD risk.
  • To explore the hypothesis that PARP-1 polymorphisms lead to gene overexpression, contributing to AD.

Main Methods:

  • A case-control study was conducted.
  • 263 Spanish patients diagnosed with AD were compared with 293 healthy controls.
  • Genotyping was performed for PARP-1 (-410, -1672) and IL-1A (-889) polymorphisms.

Main Results:

  • PARP-1 -410 and -1672 haplotypes were significantly associated with an increased risk of developing AD (p=0.019).
  • A notable interaction was found where PARP-1 haplotypes amplified AD risk in conjunction with the IL-1A -889 allele 2.
  • These findings suggest a combined genetic influence on AD pathogenesis.

Conclusions:

  • Specific PARP-1 gene polymorphisms are associated with an elevated risk for Alzheimer's disease.
  • The interaction between PARP-1 and IL-1A genetic variants may play a crucial role in AD development.
  • Further research into these genetic factors could offer insights into AD prevention and treatment strategies.

More Related Videos

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment07:26

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration04:41

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration

Published on: January 9, 2020

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Exon Recombination02:32

Exon Recombination

The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes. 
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...